Imagen de Portada

Narrative update of clinical trials with antihypertensive drugs in children and adolescents

To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Redón i Mas, Josep (Autor) , Seeman, Tomas (Autor) , Pall, Dénes (Autor) , Suurorg, Lagle (Autor) , Kamperis, Konstantinos (Autor) , Erdine, Serap (Autor) , Wühl, Elke (Autor) , Mancia, Giuseppe (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 21 November 2022
In: Frontiers in Cardiovascular Medicine
Year: 2022, Volumen: 9, Pages: 1-12
ISSN:2297-055X
DOI:10.3389/fcvm.2022.1042190
Acceso en línea:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fcvm.2022.1042190
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042190
Enlace del recurso
Notas de Autor:Josep Redon, Tomas Seeman, Dénes Pall, Lagle Suurorg, Konstantinos Kamperis, Serap Erdine, Elke Wühl and Giuseppe Mancia
Descripción
Sumario:To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials carried out in primary and secondary hypertension.
Notas:Gesehen am 09.11.2023
Descripción Física:Online Resource
ISSN:2297-055X
DOI:10.3389/fcvm.2022.1042190

Ejemplares similares